These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 772172)

  • 21. The effects of chlordiazepoxide on self-rated depression, anxiety, and well-being.
    Kellner R; Rada RT; Andersen T; Pathak D
    Psychopharmacology (Berl); 1979 Aug; 64(2):185-91. PubMed ID: 115039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of control techniques on therapeutic outcome in a controlled clinical trial.
    Hanlon TE; Blatchley RJ; Kurland AA
    Int Pharmacopsychiatry; 1975; 10(3):169-76. PubMed ID: 1099048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical physiological study of the therapeutic effects of phenytoin in acute alcohol withdrawal and the asthenic-autonomic syndrome in patients with chronic alcoholism.
    Ilyuchina VA; Nikitina LI
    Alcohol; 1995; 12(6):511-7. PubMed ID: 8590611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification.
    Liappas J; Paparrigopoulos T; Tzavellas E; Rabavilas A
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):55-60. PubMed ID: 15610945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of fluoxetine at antidepressant doses on short-term outcome of detoxified alcoholics.
    Janiri L; Gobbi G; Mannelli P; Pozzi G; Serretti A; Tempesta E
    Int Clin Psychopharmacol; 1996 Jun; 11(2):109-17. PubMed ID: 8803648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tiotixene and thioridazine in alcoholism treatment.
    Turek IS; Ota K; Brown C; Massari F; Kurland AA
    Q J Stud Alcohol; 1973 Sep; 34(3):853-9. PubMed ID: 4582597
    [No Abstract]   [Full Text] [Related]  

  • 27. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
    J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.
    Addolorato G; Balducci G; Capristo E; Attilia ML; Taggi F; Gasbarrini G; Ceccanti M
    Alcohol Clin Exp Res; 1999 Oct; 23(10):1596-604. PubMed ID: 10549990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial.
    Reoux JP; Saxon AJ; Malte CA; Baer JS; Sloan KL
    Alcohol Clin Exp Res; 2001 Sep; 25(9):1324-9. PubMed ID: 11584152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical symptomatology and computer analyzed EEG before, during and after anxiolytic therapy of alcohol withdrawal patients.
    Saletu M; Saletu B; Grünberger J; Mader R; Karobath M
    Neuropsychobiology; 1983; 9(2-3):119-34. PubMed ID: 6353268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism.
    Kampman KM; Pettinati HM; Lynch KG; Whittingham T; Macfadden W; Dackis C; Tirado C; Oslin DW; Sparkman T; O'Brien CP
    J Clin Psychopharmacol; 2007 Aug; 27(4):344-51. PubMed ID: 17632217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trazodone, a new antidepressant: efficacy and safety in endogenous depression.
    Kellams JJ; Klapper MH; Small JG
    J Clin Psychiatry; 1979 Sep; 40(9):390-5. PubMed ID: 383704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of intranasal oxytocin on alcohol withdrawal syndrome: A randomized placebo-controlled double-blind clinical trial.
    Melby K; Gråwe RW; Aamo TO; Salvesen Ø; Spigset O
    Drug Alcohol Depend; 2019 Apr; 197():95-101. PubMed ID: 30784955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
    Small GW; Bystritsky A
    J Clin Psychiatry; 1997; 58 Suppl 11():24-9. PubMed ID: 9363045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Experiences with thioridazine in the treatment of withdrawal symptoms in alcoholics].
    Masarik J; Mamoli B
    Wien Med Wochenschr; 1973 Aug; 123(31):493-5. PubMed ID: 4747005
    [No Abstract]   [Full Text] [Related]  

  • 37. The alcoholic patient: an overview and perspective.
    Khantzian EJ
    Am J Psychother; 1980 Jan; 34(1):4-19. PubMed ID: 6102850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of doxepin and thioridazine in outpatients.
    Glick BS
    Dis Nerv Syst; 1973 Jan; 34(1):37-9. PubMed ID: 4709189
    [No Abstract]   [Full Text] [Related]  

  • 39. Gender Differences in Affects and Craving in Alcohol-Dependence: A Study During Alcohol Detoxification.
    Petit G; Luminet O; Cordovil de Sousa Uva M; Monhonval P; Leclercq S; Spilliaert Q; Zammit F; Maurage P; de Timary P
    Alcohol Clin Exp Res; 2017 Feb; 41(2):421-431. PubMed ID: 28060415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of pregabalin in the treatment of alcohol withdrawal syndrome: a randomized placebo-controlled trial.
    Förg A; Hein J; Volkmar K; Winter M; Richter C; Heinz A; Müller CA
    Alcohol Alcohol; 2012; 47(2):149-55. PubMed ID: 22215002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.